MedPath

MERCK SHARP & DOHME (AUSTRALIA) PTY LTD

🇦🇺Australia
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

79

TGA:79

Drug Approvals

WELIREG belzutifan 40 mg film-coated tablet blister pack (482705)

Product Name
WELIREG belzutifan 40 mg film-coated tablet blister pack
Approval Date
Jun 25, 2025
TGA

CAPVAXIVE Pneumococcal 21-valent Conjugate Vaccine 0.5 mL Solution for Injection Pre-filled Syringe (429290)

Product Name
CAPVAXIVE Pneumococcal 21-valent Conjugate Vaccine 0.5 mL Solution for Injection Pre-filled Syringe
Approval Date
Feb 5, 2025
TGA

WINREVAIR sotatercept 45 mg powder for injection vial (433670)

Product Name
WINREVAIR sotatercept 45 mg powder for injection vial
Approval Date
Nov 8, 2024
TGA

WINREVAIR sotatercept 60 mg powder for injection vial (433671)

Product Name
WINREVAIR sotatercept 60 mg powder for injection vial
Approval Date
Nov 8, 2024
TGA

JANUVIA sitagliptin 25mg (as phosphate monohydrate) tablet blister pack (408437)

Product Name
JANUVIA sitagliptin 25mg (as phosphate monohydrate) tablet blister pack
Approval Date
Aug 2, 2023
TGA

JANUVIA sitagliptin 100mg (as phosphate monohydrate) tablet blister pack (408435)

Product Name
JANUVIA sitagliptin 100mg (as phosphate monohydrate) tablet blister pack
Approval Date
Aug 2, 2023
TGA

XELEVIA sitagliptin (as phosphate monohydrate) 25 mg film-coated tablet blister pack (408440)

Product Name
XELEVIA sitagliptin (as phosphate monohydrate) 25 mg film-coated tablet blister pack
Approval Date
Aug 2, 2023
TGA

JANUVIA sitagliptin 50mg (as phosphate monohydrate) tablet blister pack (408436)

Product Name
JANUVIA sitagliptin 50mg (as phosphate monohydrate) tablet blister pack
Approval Date
Aug 2, 2023
TGA

XELEVIA sitagliptin (as phosphate monohydrate) 100 mg film-coated tablet blister pack (408438)

Product Name
XELEVIA sitagliptin (as phosphate monohydrate) 100 mg film-coated tablet blister pack
Approval Date
Aug 2, 2023
TGA

XELEVIA sitagliptin (as phosphate monohydrate) 50 mg film-coated tablet blister pack (408439)

Product Name
XELEVIA sitagliptin (as phosphate monohydrate) 50 mg film-coated tablet blister pack
Approval Date
Aug 2, 2023
TGA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 8
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.